Should we try the antiinflammatory natural product, celastrol, for COVID-19?
- PMID: 32347602
- PMCID: PMC7267639
- DOI: 10.1002/ptr.6711
Should we try the antiinflammatory natural product, celastrol, for COVID-19?
Conflict of interest statement
The authors declare that there is no conflict of interest.
Comment on
-
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5. Cell. 2020. PMID: 32142651 Free PMC article.
References
-
- Fan, H. H. , Wang, L. Q. , Liu, W. L. , An, X. P. , Liu, Z. D. , He, X. Q. , … Tong, Y. G. (2020). Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019‐novel coronavirus (2019‐nCoV) related coronavirus model. Chinese Medical Journal, 1. 10.1097/CM9.0000000000000797 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
